First Autologous Cell Therapy of Cerebral Palsy Caused by Hypoxic-Ischemic Brain Damage in a Child after Cardiac Arrest—Individual Treatment with Cord Blood
Each year, thousands of children incur brain damage that results in lifelong sequelae. Therefore, based on experimental evidence, we explored the therapeutic potential of human cord blood, known to contain stem cells, to examine the functional neuroregeneration in a child with cerebral palsy after c...
Saved in:
Main Authors: | A. Jensen, E. Hamelmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2013/951827 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First Autologous Cord Blood Therapy for Pediatric Ischemic Stroke and Cerebral Palsy Caused by Cephalic Molding during Birth: Individual Treatment with Mononuclear Cells
by: A. Jensen, et al.
Published: (2016-01-01) -
Autologous Cord Blood Therapy for Infantile Cerebral Palsy: From Bench to Bedside
by: A. Jensen
Published: (2014-01-01) -
Melatonin in Hypoxic-Ischemic Brain Injury in Term and Preterm Babies
by: Justyna Paprocka, et al.
Published: (2019-01-01) -
Glucocorticoids and Preterm Hypoxic-Ischemic Brain Injury: The Good and the Bad
by: Laura Bennet, et al.
Published: (2012-01-01) -
A Clinical Study of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy Patients: A New Frontier
by: Alok Sharma, et al.
Published: (2015-01-01)